Roger Franklin

Education: M.Biochem (1st class), Molecular & Cellular Biochemistry, University of Oxford (UK), PhD, MRC Laboratory of Molecular Biology from University of Cambridge (UK).

Other ongoing assignments: Partner at Hadean Ventures. Director at Gesynta Pharma AB, Crosslanes Holding AB and TargED Biopharmaceuticals B.V. Deputy Director at HVentures AB. Board observer at Step Pharma SAS, Pipeline Therapeutics Inc, Emergence Therapeutics AG, and Cardior Pharmaceuticals GmbH.